Although the precise mechanism underlying the coexistence of pSS and NMOSD remains unclear, the formation of AQP4 antibodies is widely recognized as a crucial pathogenic factor in disease progression and clinical onset (20–22). This evidence concerns the gene AQP4 and peeling skin syndrome.